コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 All mice exhibited lymphoproliferation and plasmacytosis.
2 rked germinal center formation and medullary plasmacytosis.
3 lymphadenopathy, hypergammaglobulinemia, and plasmacytosis.
4 t count, M-protein concentration, and marrow plasmacytosis.
7 normal at birth, but they develop over time plasmacytosis and hypergammaglobulinemia, as well as sys
9 lial responses, including excessive reactive plasmacytosis and iron-laden macrophages, were present a
11 of 20 patients with myeloma, 2 patients with plasmacytosis associated with the acquired immunodeficie
12 dy-mediated IL-10 receptor blockade to study plasmacytosis-associated IL-10 expression and its effect
14 LC level <50 mg/L showed smaller bone marrow plasmacytosis compared to patients with a dFLC level >/=
15 th the highest-risk SMM (extreme bone marrow plasmacytosis, extremely abnormal serum immunoglobulin f
16 ring conditions of polyclonal and neoplastic plasmacytosis for the regulation of immunity and its eff
17 per L circulating monoclonal plasma cells or plasmacytosis >20% of the differential white cell count)
20 suggested by the follicular hyperplasia and plasmacytosis in lymph nodes of unimmunized animals, inc
21 oid, erythroid, and megakaryocytic lineages; plasmacytosis in spleen and lymph nodes; hepatosplenomeg
22 , lamina propria chronic inflammation, basal plasmacytosis, lamina propria and epithelial neutrophils
23 e lesions and distinguishes MM from reactive plasmacytosis, NHLs with plasmacytoid differentiation, a
24 ach mass: Follicular hyperplasia and diffuse plasmacytosis of the thymus were found but not evidence
25 ple previous relapses (for women), and basal plasmacytosis on rectal biopsy specimens were independen
26 ard ratio, 1.6 per prior relapse), and basal plasmacytosis (P = 0.003; hazard ratio, 4.5) on rectal b